Telomere Therapeutics is a pioneering gene therapy company focused on telomere repair as a treatment for fibrosis-related diseases and other syndromes where telomeres are dysfunctional. Telomere Therapeutics is developing a therapy based on the expression of the telomerase gene through an adeno-associated viral (AAV) vector to treat idiopathic pulmonary fibrosis (IPF). This disease has no cure, is associated with high mortality, and has a median life expectancy of less than 5 years after diagnosis.
José Bayón, dir. public affairs GDELS
Gonzalo León, executive committee Innovative Companies Forum
Micaela Martelli, Director of Sectorial Solutions Telefónica
Blanca Caballero, CEO Nanological
Carolina Gago, COO IOT Lenses
Amalio Garrido, CEO Drage&Mate
Mª Jesús Romero, dir. of economy and industry, Madrid City Council
Marina Villegas, General Director of Research and Technological Innovation Community of Madrid
Mª Inmaculada López, Director Compluemprende
Eduardo Díaz, Director of EBT Office Fund. Madri+d
Luis Baratas, head of entrepreneurship sector, ICEX